Skip to content

Circles

N

NovoCure Ltd

NVCR· Nasdaq

N

NVCRNovoCure Ltd

NVCRNovoCure Ltd·Earnings record

Q2 2015

Source filing unavailable

Previous · Q1 2015 Next · Q3 2015

Q2 2015 · —

Revenue

$6.54M

no prior Q2 2014 on file

Net Income

-$29.36M

no prior Q2 2014 on file

EPS Diluted

-$2.36

no prior Q2 2014 on file

Gross Profit$1,793,000—

Operating Income-$27,206,000—

Operating Cash Flow-$23,191,000

Same quarter

no prior Q2 2014 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Filing lag

Quarterly history

Q3 ’14 Q4 ’14^d Q1 ’15Q2 ’15Q3 ’15 Q4 ’15 Q1 ’16 Q2 ’16 Q3 ’16…

NovoCure Ltd · CIK 1645113 · Engraved from SEC EDGAR

—

Free Cash Flowderived-$24,999,000—

Margins · derived

Gross margin27.4%

Operating margin-415.8%

Net margin-448.7%

Thaler ResearchEngraved from SEC EDGAR© 2026 Thaler. All rights reserved.Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Platform

Using AI API SDKs CLI

Research

News Listen Earnings Insiders Holders Compare Metrics

Screener Watchlists Pies Notes Your companies

Learn

Thaler

Thaler Agent Promise Provenance Circles Account Terms Privacy